MECP2 and neuroblastoma: For an initial assessment of this hypothesis, chromatin from the MYCN amplified neuroblastoma cell line Kelly was immunoprecipitated with an anti-MeCP2 antibody and then hybridized to the NimbleGen HG18 two-array promoter set and to a custom designed tiling array representing 528 miRNA loci, as described previously [9].